Venus Medtech-B (02500.HK) Confirms No Inside Information or Disclosure Obligations Regarding Patent Infringement Litigation Involving Subsidiary Cardiovalve Ltd.

Venus Medtech-B(02500) announced that it hereby refers to recent news articles regarding Cardiovalve Ltd. (a wholly-owned subsidiary of Venus Medtech (Hangzhou) Inc. (the Company)) and MTH IP, L.P. (a joint venture of the Company) filing a patent infringement lawsuit against Edwards Lifesciences Corp. and Edwards Lifesciences LLC in the U.S. District Court for the District of Delaware. After making reasonable inquiries under the circumstances, the Company confirms that it is not aware of any information that needs to be disclosed to avoid creating a false market for the Company’s securities, or any inside information that must be disclosed under Rule 13.09(2) of the Listing Rules and Part XIVA of the Securities and Futures Ordinance.